PODCAST · health
Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies
by Annenberg Center for Health Sciences
The treatment of persons with hemophilia continues to evolve, with important advancements that address limitations with factor replacement such as diminished efficacy in patients with inhibitors and the burden of frequent intravenous administration. This 30-minute activity delves into the latest research presented at ISTH 2025, highlighting rebalancing agents and factor VIII mimetics. In addition to discussing details of each trial, Dr. von Drygalski shares her thoughts about its importance and relevance to clinical practice.
-
3
Conclusions
Dr. von Drygalski shares her thoughts about the importance of this research and its relevance to clinical practice.
-
2
Factor VIII Mimetics
Abstract 4: Effectiveness of emicizumab in hemophilia A: A 4th interim analysis of the real-world study EMIIL Abstract 5: Prospective evaluation of a defined replacement protocol for peri-operative hemostasis in patients with severe hemophilia A with and without inhibitors on emicizumab prophylaxis undergoing elective major surgeries-final results. (EmiSurg Study)Abstract 6: FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of emicizumab
-
1
A Focus on Rebalancing Agents
Abstract 1: Association of antithrombin levels with efficacy of fitusiran prophylaxis in people with hemophilia A or B with and without inhibitors: a predictive modeling approachAbstract 2: Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 studyAbstract 3: Long-term efficacy of marstacimab in participants with severe hemophilia A or B without inhibitors
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The treatment of persons with hemophilia continues to evolve, with important advancements that address limitations with factor replacement such as diminished efficacy in patients with inhibitors and the burden of frequent intravenous administration. This 30-minute activity delves into the latest research presented at ISTH 2025, highlighting rebalancing agents and factor VIII mimetics. In addition to discussing details of each trial, Dr. von Drygalski shares her thoughts about its importance and relevance to clinical practice.
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies have?
Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies currently has 3 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies about?
The treatment of persons with hemophilia continues to evolve, with important advancements that address limitations with factor replacement such as diminished efficacy in patients with inhibitors and the burden of frequent intravenous administration. This 30-minute activity delves into the latest...
How often does Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies release new episodes?
Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies has 3 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies?
You can listen to Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies?
Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies is created and hosted by Annenberg Center for Health Sciences.
URL copied to clipboard!